China Smart Insulin Pens Market Research Report: Forecast (2025-2030)

Market Definition

Smart insulin pens are advanced medical tools that can be connected to smartphones through different mobile applications, such as Bluetooth or Wi-Fi connections, to deliver insulin to diabetic patients through real-time monitoring systems for insulin levels in the body. 

Market Insights & Analysis: China Smart Insulin Pens Market (2025-30):

The China Smart Insulin Pens Market size was valued at around USD129 million in 2024 and is projected to reach USD392 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 20.35% during the forecast period, i.e., 2025-30. The market growth is driven by several factors, including the continuously rising prevalence of diabetes in the country, technological innovations, and the integration of the Internet of Things (IoT) and Artificial Intelligence (AI) in medical devices.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the Chinese government is supporting the market’s growth by drafting several policies such as the Beijing Action Plan, the 14^th Five-Year Plan, etc., to expand the medical devices industry and promote the integration of Information Technology in these devices. Similarly, through a substantial amount of investments in medical devices, including insulin delivery systems such as smart insulin pens, these are providing ample amount of opportunities for the market’s growth in China.

Also, the rapid improvement of healthcare infrastructure including the development of hospitals and clinics in rural areas is contributing to the market’s growth. It allows advanced medical facilities and accessibility to underprivileged citizens for regular medical checkups for diseases such as diabetes in the country which further motivates the patients to purchase smart insulin pens from the primary hospital pharmacies.  Moreover, technological advancements are leading to the integration of smart insulin pens with glucose monitoring systems that give alerts to patients when the insulin levels are low in the body, thus creating more convenience and encouraging self-management for insulin delivery. These are shaping the growth of China’s Smart Insulin Pens Market.

China Smart Insulin Pens Market Driver:

Widespread Incidence of Diabetes – The high burden of diabetes in the country is increasing the demand for smooth and safe insulin delivery, thus becoming a key driver of the smart insulin pens industry, which can safely deliver insulin to diabetic patients and be monitored digitally. It is rapidly increasing due to various factors, including the rising elderly population in the country, sedentary lifestyle, obesity risks, stress, heredity, etc. As per the International Diabetes Federation (2021), China has around 0.14 billion diabetic patients, which is about 13% of the total population in China, and it is further projected to rise in the country.

Additionally, the elderly population is more prone to chronic diseases such as diabetes due to weak immune systems as compared to the younger population. China has one of the largest senior citizens aged above 60 years. As per the State Council of China (2035), there were more than 296 million older individuals almost 22% of the total population in the country which is further expected to rise and reach up to 35% by 2035.

China Smart Insulin Pens Market Opportunity:

Government Policies to Encourage Digitalization in the Healthcare Industry – The Chinese government is actively supporting the integration of the Internet of Things (IoT), Artificial Intelligence, and Digitalization in the healthcare sector, including medical devices and instruments by drafting various policies. Thus, creating significant opportunities for the smart insulin pens industry to grow significantly in China.

As per the Asian Development Bank Institute (2024), China’s Ministry of Industry and Information Technology and the National Health & Family Planning Commission issued a joint initiative called Smart Healthcare Industry Development Action Plan (2021-25) to promote digitalization and smart hardware in the medical equipment and devices to advance care for elderly people and to modernize the healthcare Industry in China. Such initiatives are contributing to the potential growth of the market.

China Smart Insulin Pens Market Challenge:

Increased Vulnerability to Cyber Threats – The smart insulin pens can be connected to various platforms such as smartphones through Bluetooth, an internet connection, or mobile applications. It is leading to the collection of sensitive and personal data of the individual, which is under the cyber threat. As per TechCrunch (2022), China has faced a significant data breach of more than 1 billion personal health data of Chinese residents from the database. Additionally, smart devices like insulin pens have weak encryption and less security related to personal information. It is leading to trust issues among individuals and they continue to use traditional kinds of insulin delivery systems, thus decreasing the demand for smart insulin pens.

Additionally, one of the main reasons involved in the data breach of smart devices like smart insulin pens is the integration of third-party mobile applications. Some of them offer less data security and are at high risk of data breaches by hackers, therefore hindering the market’s growth.

China Smart Insulin Pens Market Trend:

Integration of Smart Insulin Pens with Other Modern Medical Devices – The market is significantly growing due to the rising incorporation of other advanced medical devices such as Continuous Glucose Monitoring Systems (CGMs), Electronic Health Records (EHR), etc. This integration allows the devices to function more precisely and efficiently. 

Several companies like Micro Tech Medical, Medtrum, Sinocare, etc. have started manufacturing integrated smart insulin pens with Continuous Glucose Monitoring systems. For instance, in 2024, Abbott launched a product called Bigfoot Unity, which is a smart insulin pen that can be paired with the GCM system through its cap to actively navigate the insulin delivery based on real-time blood glucose levels. Moreover, many companies like Medtronic, Companion Medical, Roche Diabetes Care, etc., are manufacturing these devices with a combination of electronic health record systems, thus shaping the market’s growth.

China Smart Insulin Pens Market (2025-30): Segmentation Analysis

The China Smart Insulin Pens Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the national level. Based on the analysis, the market has been further classified as:

Based on Product Type:

• First-Generation Pens
• Second-Generation Pens

Out of these, Second Generation Insulin Pens hold the largest market share of more than 55%. The reason behind the market growth due to this segment is the rising adoption of digitalization and automation in medical devices that can be easily used by a large number of diabetic patients with low insulin levels. The rapidly growing technological advancements in the healthcare sector are leading to the robust adoption of second-generation insulin pens in the country, which can be connected through smartphones.

Some China-based companies such as Novo Nordisk, Medtronic, Medtrum, and Companion are actively manufacturing the 2nd-generation insulin pens in the country due to their high demand, as the number of diabetic patients is continuously increasing in China. For example, the regulatory Authority of China called the National Medical Products Administration (NMPA) (2022) approved the Novo Pen 6, a second-generation insulin pen manufactured by the Novo Nordisk company in China. In 2024, as per Aman Alliance, Novo Nordisk increased its productivity and exported almost 2.5 million 2nd-generation smart insulin pens to Saudi Arabia and generated almost USD12 million in revenue. Such expansions and cross-border trades are leading to the growth of this segment in the market.

Based on Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online/E-commerce

Among these, Hospital Pharmacies are dominating the market and accounting for more than 40% share of the overall market volume. The factor contributing to the segmental revenue’s growth is the large volume of visits of diabetic patients to hospitals for regular check-ups, so they prefer to take medications, including insulin pens from the corresponding hospital pharmacies. Additionally, the beliefs related to the pharmacies in hospitals are contributing to the market’s growth. Moreover, some of the medications including insulin delivery systems are prescription-drugs only in China, that is only written in hospitals during the checkups, so it makes it easier for the patients to purchase the insulin pens from the nearest distribution channel that is the hospital pharmacies, thus leading the growth of this segment in the smart insulin pens industry in China.

China Smart Insulin Pens Industry Recent Development:

• 2025: Novo Nordisk has launched a smart cap called Mallya for smart insulin pens that are attached with hidden sensors that can automatically record insulin delivery data such as insulin dosage, time of delivery, etc., and can send alerts to the individual through Bluetooth and mobile app connections.
• 2024: Sinocare Inc. has launched a new smart insulin pen that is integrated with a next-generation Continuous Monitoring system to monitor real-time blood glucose levels to deliver insulin at appropriate times.

Gain a Competitive Edge with Our China Smart Insulin Pens Market Report

1. China Smart Insulin Pens Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. China Smart Insulin Pens Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.